SNGX · Soligenix, Inc.
Market Cap
$8.20M
Shares
21.77M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.38
Open$0.38
Day$0.36–0.39
52W close$0.28–3.11
Avg vol 30d260K
Short int208K · 1.0% float · 1.2d
Short vol52%
DataJun 2024–Aug 2026
Filing10-Q · Aug 7
Raw chart and full-history price indicators begin at the captured split on Jun 6, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−58%
below
Price vs 50-day avg
−0%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
4%
near low
Momentum
relative strength
1-month return
+1%
trailing
6-month return
−69%
trailing
YTD return
−72%
this year
Relative strength
−82%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+13% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.95% of float · ▼ -64.5% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — mid 3-yr range
Squeeze score
32
low risk · 0–100
Fundamentals
Revenue growth
−86%
Y/Y
Gross margin
82%
expanding
EPS growth
+57%
Y/Y
Free cash flow
$-10.3M
Balance sheet
$7.8M
net cash
Quant / Vol
risk profile
Volatility
139%
annualized · 1-yr
Max drawdown
−91%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−58%
Bearish
Price vs 50-day avg
−0%
Neutral
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
4%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+13% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.95% of float · ▼ -64.5% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
17 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 4%
Range high $3
vs 200-day avg -58%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNGX
this stock
Soligenix, Inc.
|
$8.20M | -71.6% | -85.8% | — | 1.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.1% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +3.5% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.51B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Jun 6, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNGX | -6.1% | +0.7% | -69.1% | +2.7% | -71.6% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -6.6% | -0.6% | -82.4% | +0.0% | -84.1% |
Key facts
CIK
812796
CUSIP
834223604
13F (30d)
15 filings
15 filers
Visit website
Investor relations